News

Scientists have developed a hydrogel “rest stop” that shields cancer-fighting T cells, delaying their exhaustion and boosting ...
The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.
A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...
INDIANAPOLIS (WISH) — it’s a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a ...
Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...
Whether it’s for fun or for work — we’ve all spent too much time in the sun before. However, sun exposure is the leading ...
The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country's largest and ...
The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country's largest and most advanced cancer research and treatment organizations, today announced the ...
Researchers find that disrupted circadian rhythms may impair gut regeneration and microbiome balance, heightening colon cancer susceptibility.
Although anti-PD-1 therapy, alone or in combination with an anti-CTLA-4 agent, has become the first-line standard of care for ...
Beth Ferguson’s doctor initially said “there was nothing to worry about” after she found a lump on her left breast because ...
Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, yet many tumors remain resistant. Now, ...